025860 — Namhae Chemical Balance Sheet
0.000.00%
- KR₩341bn
- KR₩490bn
- KR₩2tn
- 59
- 75
- 14
- 47
Annual balance sheet for Namhae Chemical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 147,125 | 172,753 | 89,504 | 29,502 | 41,707 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 71,838 | 64,341 | 112,476 | 182,218 | 202,882 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 373,809 | 383,051 | 503,297 | 618,409 | 499,607 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 172,081 | 171,196 | 165,186 | 219,808 | 268,699 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 581,139 | 589,445 | 719,111 | 902,896 | 833,549 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 126,716 | 118,788 | 232,132 | 361,478 | 272,183 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 147,179 | 136,526 | 251,707 | 391,271 | 323,291 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 433,960 | 452,919 | 467,403 | 511,626 | 510,257 |
Total Liabilities & Shareholders' Equity | 581,139 | 589,445 | 719,111 | 902,896 | 833,549 |
Total Common Shares Outstanding |